Recent research indicates a growing possibility of remission from type 2 diabetes, challenging the long-held belief that the condition is invariably progressive. A narrative review published in Diabetes Therapy in June 2025, authored by Salvatore Corrao and colleagues at the ARNAS Civico hospital in Palermo, Italy, examines the current evidence and integrated care strategies for achieving remission.
The review highlights that remission is becoming increasingly attainable, though not through a single, standardized approach. This aligns with findings reported by Medscape, which emphasizes the evolving understanding of type 2 diabetes and the potential for reversal of the disease. The Italian researchers’ work builds on a growing body of evidence suggesting that tailored interventions can induce remission, particularly in newly diagnosed patients willing to adhere to strict protocols, as detailed in a systematic review and meta-analysis published in Diabetes Care.
Multiple pathways are now recognized as potentially leading to remission. These include significant weight loss, bariatric surgery, pharmacotherapy, and intensive lifestyle changes, according to Medscape. The Diabetes Therapy review suggests an integrated care strategy is crucial, though the specifics of such strategies require further investigation. The global impact of type 2 diabetes is substantial, with projections estimating 629 million people will be affected by 2045, underscoring the importance of finding effective remission strategies.
While the prospect of remission offers hope, researchers emphasize the require for further study into the long-term sustainability and effectiveness of different approaches. Patient preferences also play a critical role in determining the most appropriate and successful intervention. The Italian research team, based at the University of Palermo, is actively investigating these factors within the context of integrated care models.
